Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anticitrullinated protein antibody status and bioligical use

dc.article.end-page10en
dc.article.start-page1en
dc.citation.doi10.1136/RMDOPEN-2025-005464en
dc.contributor.authorG Karpouzasen
dc.contributor.authorMiguel Gonzalez-Gayen
dc.contributor.authorA Corralesen
dc.contributor.authorE Myasoedovaen
dc.contributor.authorSolbritt Rantapaa-Dahlqvisten
dc.contributor.authorPatrick Desseinen
dc.contributor.authorE et alen
dc.date.accessioned2026-04-08T16:06:40Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2056-5933en
dc.identifier.urihttps://hdl.handle.net/10539/48932
dc.journal.titleInfluence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anticitrullinated protein antibody status and bioligical useen
dc.journal.volume1en
dc.titleInfluence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anticitrullinated protein antibody status and bioligical useen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
2.12 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client